156 related articles for article (PubMed ID: 33748101)
21. Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium.
Liu T; Jabbes M; Nedrow-Byers JR; Wu LY; Bryan JN; Berkman CE
Int J Oncol; 2011 May; 38(5):1349-55. PubMed ID: 21331445
[TBL] [Abstract][Full Text] [Related]
22. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
Chang HH; Cheng YC; Tsai WC; Chen Y
Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
[TBL] [Abstract][Full Text] [Related]
23. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
24. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.
Brunckhorst MK; Wang H; Lu R; Yu Q
Cancer Res; 2010 Sep; 70(18):7283-93. PubMed ID: 20823154
[TBL] [Abstract][Full Text] [Related]
25. Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-
Li W; Cai H; Ren L; Yang Y; Yang H; Liu J; Li S; Zhang Y; Zheng X; Tan W; Du G; Wang J
Acta Pharm Sin B; 2022 Dec; 12(12):4390-4406. PubMed ID: 36562002
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts.
Falchetti ML; Mongiardi MP; Fiorenzo P; Petrucci G; Pierconti F; D'Agnano I; D'Alessandris G; Alessandri G; Gelati M; Ricci-Vitiani L; Maira G; Larocca LM; Levi A; Pallini R
Int J Cancer; 2008 Mar; 122(6):1236-42. PubMed ID: 18027853
[TBL] [Abstract][Full Text] [Related]
27. circFLNA promotes glioblastoma proliferation and invasion by negatively regulating miR‑199‑3p expression.
Sun Y; Ma G; Xiang H; Wang X; Wang H; Zhang Y; Qie F; Li C
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498720
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.
Yang H; Song Z; Wu X; Wu Y; Liu C
Onco Targets Ther; 2019; 12():5563-5575. PubMed ID: 31371994
[TBL] [Abstract][Full Text] [Related]
29. FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.
Yang B; Liu D; Ren YQ; Sun YQ; Zhang JP; Wang XG; Wu YQ; Wang SL; Guo SH; Guo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35059733
[TBL] [Abstract][Full Text] [Related]
30. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
31. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
[TBL] [Abstract][Full Text] [Related]
32. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
Xu X; Zhang F; Chen X; Ying Q
Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
[TBL] [Abstract][Full Text] [Related]
34. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways.
Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L
Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
Liu Z; Guo N; Zhang XJ
Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
[TBL] [Abstract][Full Text] [Related]
36. Midkine promotes glioblastoma progression via PI3K-Akt signaling.
Hu B; Qin C; Li L; Wei L; Mo X; Fan H; Lei Y; Wei F; Zou D
Cancer Cell Int; 2021 Sep; 21(1):509. PubMed ID: 34556138
[TBL] [Abstract][Full Text] [Related]
37. Juglone reduces growth and migration of U251 glioblastoma cells and disrupts angiogenesis.
Wang J; Liu K; Wang XF; Sun DJ
Oncol Rep; 2017 Oct; 38(4):1959-1966. PubMed ID: 28791366
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.
Yang P; Kang W; Pan Y; Zhao X; Duan L
Cancer Manag Res; 2019; 11():8167-8179. PubMed ID: 31564976
[TBL] [Abstract][Full Text] [Related]
39. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases.
Nomura N; Pastorino S; Jiang P; Lambert G; Crawford JR; Gymnopoulos M; Piccioni D; Juarez T; Pingle SC; Makale M; Kesari S
Cancer Cell Int; 2014 Mar; 14(1):26. PubMed ID: 24645697
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder.
Li Y; Zhang K; Yang F; Jiao D; Li M; Zhao X; Xu C; Liu S; Li H; Shi S; Yang B; Yang L; Han D; Wen W; Qin W
Front Oncol; 2021; 11():771036. PubMed ID: 34869004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
